Aaron Goodman

Aaron Goodman, MD, is an Associate Professor of Medicine at the UC San Diego School of Medicine and a hematologist specializing in blood cancers, including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and multiple myeloma. He is part of the UC San Diego Health/Sharp HealthCare Blood and Marrow Transplantation (BMT) Program, offering comprehensive care from diagnosis to survivorship. Dr. Goodman also co-founded San Diego's first comprehensive cutaneous lymphoma clinic and is involved in the National Comprehensive Cancer Network (NCCN) guideline committees for cutaneous and T-cell non-Hodgkin lymphomas.

His research focuses on immunotherapy, cellular therapy for hematologic malignancies, and biomarkers for treatment response. He has contributed to book chapters and publications in journals like Oncology and Nature Reviews Clinical Oncology. Clinically, he provides CAR T-cell therapy for relapsed B-cell lymphoma and manages rare disorders like Erdheim-Chester disease and Rosai-Dorfman disease.

Dr. Goodman completed his medical degree at Emory University, residency at Washington University (serving as chief resident), and fellowship at UC San Diego. He is board certified in internal medicine, hematology, and medical oncology. He joined UC San Diego Health in 2017.